Literature DB >> 8133461

Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application.

P Singh1, M S Roberts.   

Abstract

The time course of salicylic acid at a dermal application site and in local underlying tissues below the site in rats was examined using a physiologically based pharmacokinetic model assuming first-order diffusional mass transfer between the dermis and underlying tissues. The concentrations of salicylic acid in tissues below the applied site were measured and compared with plasma concentrations and concentrations in similar tissues on the contralateral side. The direct penetration of salicylic acid was dominant only to a depth of 3-4 mm below the applied site for the first approximately 2 hr after application. The time course of salicylic acid in individual rats was modeled using known tissue blood flows and tissue-tissue clearances by (i) numerical integration and nonlinear regression of a series of differential equations representing events in individual tissues, and (ii) numerical integration and nonlinear regression of a single differential equation representation of the concentration-time course in an individual tissue with a polynomial representation of salicylate concentrations in other input tissues and an exponential representation of the input from the solution. Tissue-tissue clearances were deduced by both nonlinear regression and mass balance analysis (only for underlying dermis) using area-under-the-curves from salicylic acid tissue penetration data in anesthetized rats. The relative importance of direct penetration and blood supply in determining the concentrations of salicylic acid in deeper tissues was assessed by simulations in which either no direct penetration occurred or there was zero input from blood. Simulations confirm that direct penetration is only evident in the superficial tissues for approximately 2 hr. An attempt was also made to examine the dermal pharmacokinetics of salicylic acid using statistical moments.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133461     DOI: 10.1007/bf01061687

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  28 in total

1.  PREPARATION OF ISOLATED SHEETS OF HUMAN STRATUM CORNEUM.

Authors:  A M KLIGMAN; E CHRISTOPHERS
Journal:  Arch Dermatol       Date:  1963-12

2.  Local enhanced topical delivery (LETD) of drugs: does it truly exist?

Authors:  S C McNeill; R O Potts; M L Francoeur
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

Review 3.  Permeability of continuous capillaries.

Authors:  W P Paaske; P Sejrsen
Journal:  Dan Med Bull       Date:  1989-12

4.  On pharmacokinetics in target tissues.

Authors:  M Weiss
Journal:  Biopharm Drug Dispos       Date:  1985 Jan-Mar       Impact factor: 1.627

5.  Mean residence time in peripheral tissue: a linear disposition parameter useful for evaluating a drug's tissue distribution.

Authors:  P Veng-Pedersen; W Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1984-10

6.  Determination of aspirin and its major metabolites in plasma by high-performance liquid chromatography without solvent extraction.

Authors:  R H Rumble; M S Roberts; S Wanwimolruk
Journal:  J Chromatogr       Date:  1981-09-11

7.  Differences in the protein binding of several drugs and bilirubin in serum and heparinized plasma of rats.

Authors:  U W Wiegand; J T Slattery; K L Hintze; G Levy
Journal:  Life Sci       Date:  1979-07-30       Impact factor: 5.037

8.  [The percutaneous absorption of diclofenac].

Authors:  W Riess; K Schmid; L Botta; K Kobayashi; J Moppert; W Schneider; A Sioufi; A Strusberg; M Tomasi
Journal:  Arzneimittelforschung       Date:  1986-07

9.  Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.

Authors:  J Shen; S Wanwimolruk; R D Purves; E G McQueen; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

10.  Drug permeation through human skin II: Permeability of ionizable compounds.

Authors:  J Swarbrick; G Lee; J Brom; N P Gensmantel
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

View more
  14 in total

1.  Estimation of intradermal disposition kinetics of drugs: I. Analysis by compartment model with contralateral tissues.

Authors:  K Nakayama; H Matsuura; M Asai; K Ogawara; K Higaki; T Kimura
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

2.  Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Authors:  Peng Li; Thomas A Robertson; Qian Zhang; Linda M Fletcher; Darrell H G Crawford; Michael Weiss; Michael S Roberts
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

3.  Iontophoresis-facilitated delivery of prednisolone through throat skin to the trachea after topical application of its succinate salt.

Authors:  Hiroshi Ishii; Tsukasa Suzuki; Hiroaki Todo; Mitsuhiro Kamimura; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

4.  Percutaneous absorption of topically applied NSAIDS and other compounds: role of solute properties, skin physiology and delivery systems.

Authors:  M S Roberts; S E Cross
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

5.  Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application.

Authors:  S E Cross; S A Megwa; H A Benson; M S Roberts
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

6.  A physiological pharmacokinetic model for solute disposition in tissues below a topical below a topical application site.

Authors:  M S Roberts; S E Cross
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

7.  Physiologically based pharmacokinetic tissue compartment model selection in drug development and risk assessment.

Authors:  Matthew D Thompson; Daniel A Beard
Journal:  J Pharm Sci       Date:  2011-10-03       Impact factor: 3.534

Review 8.  Topical therapies for osteoarthritis.

Authors:  Roy D Altman; H Richard Barthel
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

Review 9.  Topical NSAIDs for musculoskeletal conditions. A review of the literature.

Authors:  J H Vaile; P Davis
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

10.  Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies.

Authors:  S E Cross; C Anderson; M S Roberts
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.